| Effects of exercise on lymphocytes and cytokines BK Pedersen, AD Toft British journal of sports medicine 34 (4), 246-251, 2000 | 659 | 2000 |
| Cytokine response to eccentric exercise in young and elderly humans AD Toft, LB Jensen, H Bruunsgaard, T Ibfelt, J Halkjær-Kristensen, ... American Journal of Physiology-Cell Physiology 283 (1), C289-C295, 2002 | 325 | 2002 |
| Strenuous exercise decreases the percentage of type 1 T cells in the circulation A Steensberg, AD Toft, H Bruunsgaard, M Sandmand, ... Journal of applied physiology 91 (4), 1708-1712, 2001 | 304 | 2001 |
| Plasma interleukin-6 during strenuous exercise: role of epinephrine A Steensberg, AD Toft, P Schjerling, J Halkjær-Kristensen, BK Pedersen American Journal of Physiology-Cell Physiology 281 (3), C1001-C1004, 2001 | 190 | 2001 |
| Prolonged exercise, lymphocyte apoptosis and F2-isoprostanes A Steensberg, J Morrow, A Toft, H Bruunsgaard, B Pedersen European Journal of Applied Physiology 87, 38-42, 2002 | 169 | 2002 |
| Cytokines in aging and exercise BK Pedersen, H Bruunsgaard, K Ostrowski, K Krabbe, H Hansen, ... International journal of sports medicine 21 (Sup. 1), 4-9, 2000 | 162 | 2000 |
| N-3 polyunsaturated fatty acids do not affect cytokine response to strenuous exercise AD Toft, M Thorn, K Ostrowski, S Asp, K Møller, S Iversen, C Hermann, ... Journal of applied physiology 89 (6), 2401-2406, 2000 | 144 | 2000 |
| Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme K Niswender, X Pi‐Sunyer, J Buse, KH Jensen, AD Toft, D Russell‐Jones, ... Diabetes, Obesity and Metabolism 15 (1), 42-54, 2013 | 141 | 2013 |
| Meta-analysis demonstrates that liraglutide, a once-daily human GLP-1 analogue, significantly reduces lipids and other markers of cardiovascular risk in type 2 diabetes J Plutzky, A Garber, AD Toft, NR Poulter Diabetologia 52, S299-S300, 2009 | 92 | 2009 |
| Exercise and the immune system-influence of nutrition and ageing BK Pedersen, H Bruunsgaard, M Jensen, AD Toft, H Hansen, K Ostrowski Journal of science and medicine in sport 2 (3), 234-252, 1999 | 84 | 1999 |
| Effects of eccentric cycling exercise on IGF‐I splice variant expression in the muscles of young and elderly people M Hameed, AD Toft, BK Pedersen, SDR Harridge, G Goldspink Scandinavian journal of medicine & science in sports 18 (4), 447-452, 2008 | 61 | 2008 |
| Source and kinetics of interleukin-6 in humans during exercise demonstrated by a minimally invasive model AD Toft, A Falahati, A Steensberg European journal of applied physiology 111, 1351-1359, 2011 | 58 | 2011 |
| Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis J Plutzky, A Garber, A Falahati, AD Toft, NR Poulter Canadian Journal of Diabetes 33 (3), 209-210, 2009 | 38 | 2009 |
| Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients JN Jakobsen, T Urup, K Grunnet, A Toft, MD Johansen, SH Poulsen, ... Journal of neuro-oncology 137, 439-446, 2018 | 37 | 2018 |
| The once-daily human GLP-1 analogue, liraglutide, significantly reduces markers of cardiovascular risk in type 2 diabetes: a meta-analysis of six clinical trials J Plutzky, AJ Garber, A Falahati, AD Toft, NR Poulter European Heart Journal 30, 917-917, 2009 | 29 | 2009 |
| Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients T Urup, SR Michaelsen, LR Olsen, A Toft, IJ Christensen, K Grunnet, ... Molecular Oncology 10 (8), 1160-1168, 2016 | 27 | 2016 |
| Failure of insulin monotherapy in patients with type 2 diabetes: a population-based study S Gough, K Frandsen, A Toft | 24 | 2006 |
| Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients T Urup, LM Staunstrup, SR Michaelsen, K Vitting-Seerup, M Bennedbæk, ... BMC cancer 17, 1-10, 2017 | 23 | 2017 |
| Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan T Urup, RH Dahlrot, K Grunnet, IJ Christensen, SR Michaelsen, A Toft, ... Acta Oncologica 55 (4), 418-422, 2016 | 19 | 2016 |
| Liraglutide, a human GLP‐1 analogue, lowers HbA1c independent of weight loss WE Schmidt Diabetologia 52 (1), S289, 2009 | 17 | 2009 |
